IRIS Institutional Research Information System - OPENBS Open Archive UniBS

LAPADULA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.838
AS - Asia 743
EU - Europa 579
SA - Sud America 104
AF - Africa 10
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.279
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.815
CN - Cina 315
SG - Singapore 245
DE - Germania 143
UA - Ucraina 140
BR - Brasile 92
GB - Regno Unito 83
HK - Hong Kong 80
FI - Finlandia 68
IT - Italia 30
RU - Federazione Russa 29
IE - Irlanda 24
TR - Turchia 23
FR - Francia 22
VN - Vietnam 19
IN - India 17
CA - Canada 14
IR - Iran 10
PL - Polonia 10
MX - Messico 7
JP - Giappone 6
SE - Svezia 6
AR - Argentina 5
ZA - Sudafrica 5
BD - Bangladesh 4
BE - Belgio 4
LT - Lituania 4
AT - Austria 3
AZ - Azerbaigian 3
ES - Italia 3
MA - Marocco 3
SK - Slovacchia (Repubblica Slovacca) 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
EC - Ecuador 2
EU - Europa 2
IQ - Iraq 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
NL - Olanda 2
UZ - Uzbekistan 2
AL - Albania 1
BH - Bahrain 1
CL - Cile 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
QA - Qatar 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 3.279
Salva come PNG Salva come JPEG
Città #
Woodbridge 218
Fairfield 204
Ashburn 180
Ann Arbor 131
Singapore 126
Houston 117
Jacksonville 116
Chandler 102
Hong Kong 80
Cambridge 77
Beijing 75
Seattle 74
Wilmington 71
Nanjing 49
Los Angeles 45
Helsinki 43
Princeton 42
New York 38
Lancaster 37
Munich 31
Dublin 24
The Dalles 22
Istanbul 21
Shanghai 18
Nanchang 17
Jinan 16
Shenyang 16
Des Moines 14
Tianjin 14
Changsha 13
San Diego 12
Moscow 11
San Francisco 11
Ardabil 10
Dallas 9
Hebei 9
Milan 9
Santa Clara 9
Warsaw 9
Buffalo 8
London 8
Redondo Beach 8
São Paulo 8
Toronto 8
Ho Chi Minh City 7
Dearborn 6
Frankfurt am Main 6
Kunming 6
Phoenix 6
Turku 6
Washington 6
Hangzhou 5
Ningbo 5
Tokyo 5
Atlanta 4
Augusta 4
Brussels 4
Chicago 4
Curitiba 4
Lanzhou 4
Monmouth Junction 4
Poplar 4
Porto Alegre 4
Rio de Janeiro 4
Stockholm 4
Baku 3
Bratislava 3
Brescia 3
Brooklyn 3
City of London 3
Da Nang 3
Fuzhou 3
Guangzhou 3
Haikou 3
Hanoi 3
Johannesburg 3
Mexico City 3
Montreal 3
Querétaro 3
Taiyuan 3
Belo Horizonte 2
Bishkek 2
Biên Hòa 2
Boston 2
Changchun 2
Charlotte 2
Chennai 2
Conselheiro Lafaiete 2
Denver 2
Düsseldorf 2
Hefei 2
Jiaxing 2
Kansas City 2
Leawood 2
Maricá 2
New Delhi 2
Nuremberg 2
Riga 2
Santo Antônio do Monte 2
Taizhou 2
Totale 2.347
Salva come PNG Salva come JPEG
Nome #
The Disagreement Among Methods to Evaluate Glomerular Filtration Rate in HIV-Infected Patients Naive to Antiretroviral Therapy. 219
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 205
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 158
Dideoxynucleoside HIV reverse transcriptase inhibitors and drug-related hepatotoxicity: a case report. 156
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 155
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 153
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 151
Effectiveness of antiretroviral regimens containing abacavir with tenofovir in treatment-experienced patients: predictors of virological response and drug resistance evolution in a multi-cohort study. 148
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. 148
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 147
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. 146
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 144
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 142
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: a cross-sectional study 136
Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. 131
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts 121
Plasma HIV load and proviral DNA decreases after two standard antiretroviral regimens in HIV-positive patients naïve to antiretrovirals 112
Analysis of severe hepatic events associated with nevirapine-containing regimens: CD4+ T-cell count and gender in hepatitis C seropositive and seronegative patients. 109
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy 107
Influence of hepatitis C genotypes on lipid levels in HIV-positive patients during highly active antiretroviral therapy. 105
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 103
Long-term durability of tenofovir-based antiretroviral therapy In relation to the Co-administration of other drug classes in routine clinical practice 92
Predictors of AIDS-defining events among advanced naïve patients after HAART. 91
Predictors of clinical progression among HIV-1-positive patients starting HAART with CD4+ T-cell counts > or =200 cells/mm3. 89
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 38
Totale 3.306
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.855
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021223 0 0 0 0 0 53 14 38 47 27 30 14
2021/2022221 34 21 5 10 0 12 7 16 5 30 22 59
2022/2023247 23 5 6 14 25 61 0 29 56 1 10 17
2023/2024245 11 7 25 32 12 48 13 6 55 13 4 19
2024/2025487 8 6 1 68 54 38 32 27 51 48 97 57
2025/2026516 93 93 43 117 158 12 0 0 0 0 0 0
Totale 3.306